N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride

C18H25ClF3N5S — CID 120845311

IUPACN-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride
SMILESCCn1ccnc1CN(Cc1cnc(C(F)(F)F)s1)C1CC12CCNCC2.Cl
InChIInChI=1S/C18H24F3N5S.ClH/c1-2-25-8-7-23-15(25)12-26(14-9-17(14)3-5-22-6-4-17)11-13-10-24-16(27-13)18(19,20)21;/h7-8,10,14,22H,2-6,9,11-12H2,1H3;1H
InChIKeyGOWXXCWMOLXYRK-UHFFFAOYSA-N
MW435.95 g/mol
LogP3.94
Rot. Bonds6

About N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride

N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride (PubChem CID 120845311) has the molecular formula C18H25ClF3N5S and a molecular weight of 435.95 g/mol. Its IUPAC name is N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride.

Molecular Properties

Compound NameN-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride
PubChem CID120845311
Molecular FormulaC18H25ClF3N5S
Molecular Weight435.95 g/mol
Exact Mass435.15
IUPAC NameN-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride
SMILESCCn1ccnc1CN(Cc1cnc(C(F)(F)F)s1)C1CC12CCNCC2.Cl
InChIInChI=1S/C18H24F3N5S.ClH/c1-2-25-8-7-23-15(25)12-26(14-9-17(14)3-5-22-6-4-17)11-13-10-24-16(27-13)18(19,20)21;/h7-8,10,14,22H,2-6,9,11-12H2,1H3;1H
InChIKeyGOWXXCWMOLXYRK-UHFFFAOYSA-N
XLogP3.94
TPSA45.98 Ų
H-Bond Donors1
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms28
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500435.95
LogP ≤ 53.94
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 106

Analyze N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride?
The IUPAC name of N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride (CID 120845311) is N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride.
What is the SMILES notation for N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride?
The canonical SMILES for N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride is CCn1ccnc1CN(Cc1cnc(C(F)(F)F)s1)C1CC12CCNCC2.Cl.
What is the InChIKey of N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride?
The InChIKey is GOWXXCWMOLXYRK-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H24F3N5S.ClH/c1-2-25-8-7-23-15(25)12-26(14-9-17(14)3-5-22-6-4-17)11-13-10-24-16(27-13)18(19,20)21;/h7-8,10,14,22H,2-6,9,11-12H2,1H3;1H.
What are the key properties of N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride?
N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride has a molecular weight of 435.95 g/mol, XLogP of 3.94, 6 rotatable bonds, 1 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for N-[(1-ethylimidazol-2-yl)methyl]-N-[[2-(trifluoromethyl)-1,3-thiazol-5-yl]methyl]-6-azaspiro[2.5]octan-2-amine;hydrochloride is sourced from PubChem (CID 120845311), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).